|

Validation of an Integrated Attention Model for Patients With Type 2 Diabetes

RECRUITINGN/ASponsored by Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Actively Recruiting
PhaseN/A
SponsorInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Started2013-10-31
Est. completion2018-02-09
Eligibility
Age18 Years – 70 Years
Healthy vol.Accepted

Summary

Abstract: Empowerment interventions for chronic diseases are an evolving process. No agreement exists regarding the necessary components and methodologies to be applied. Systematic reviews have assessed the effect of self-management interventions. Improvements in illness beliefs, adherence to drug therapy and glucose monitoring have been reported. In the long term, no major changes have been achieved in weight, physical activity, smoking status, and depression scores. There is a need for additional studies. The Center for Comprehensive Care of Patients with Diabetes (CAIPaDi) program is an intervention designed to provide education and empowerment techniques (using simple low-cost interactive tools) over a short period of time followed by at-distance support using internet or cell phone technology. The target population consists of patients with type 2 diabetes, free of chronic complications who are non-smokers. The intervention is composed of four monthly visits followed by a continuous at-distance support system. At each visit, patients stay for six hours in the center. Information is presented in group sessions. Empowerment techniques are applied during individual exchanges with the team or during facilitated group sessions. In summary, empowerment programs are an unmet need in many healthcare services.

Eligibility

Age: 18 Years – 70 YearsHealthy volunteers accepted
Inclusion Criteria:

* being over 18 and under 70 years old
* having diagnosis of type 2 diabetes in the five previous years,
* having family support
* free of disabling diabetes complications

Exclusion Criteria:

* advanced complications of diabetes, such as ischemic heart disease, heart failure NYHA III-IV, KDOQI ≥3 renal failure, amputations, cerebral vascular disease, gastroparesis and muscular atrophy .
* type 1 diabetes mellitus, gestational diabetes or some variant of diabetes related to genetic syndromes, hyperlabile diabetes
* co-morbidities that limit their life expectancy such as malignant tumors
* advanced cognitive impairment or serious psychiatric disorders
* smoking, alcoholism or illegal drug dependence
* conditions that require surgical treatment in the short run or which prevent moderated activity.

Conditions2

DiabetesType 2 Diabetes

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.